Cargando…

Combinatorial Strategies With PD-1/PD-L1 Immune Checkpoint Blockade for Breast Cancer Therapy: Mechanisms and Clinical Outcomes

As an emerging antitumor strategy, immune checkpoint therapy is one of the most promising anticancer therapies due to its long response duration. Antibodies against the programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) axis have been extensively applied to various cancers and have demo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Dan, Hou, Xiaolin, Yu, Jing, He, Xiujing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355550/
https://www.ncbi.nlm.nih.gov/pubmed/35935874
http://dx.doi.org/10.3389/fphar.2022.928369